Shopping Cart
Remove All
Your shopping cart is currently empty
SKLB-197 is able to act on ATR (IC50: 0.013 μM), but has little or no activity on the other 402 protein kinases. In vitro and in vivo, SKLB-197 has shown significant antitumour effects against ATM-deficient tumours.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $715 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $929 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $1,490 | 6-8 weeks | 6-8 weeks |
| Description | SKLB-197 is able to act on ATR (IC50: 0.013 μM), but has little or no activity on the other 402 protein kinases. In vitro and in vivo, SKLB-197 has shown significant antitumour effects against ATM-deficient tumours. |
| Targets&IC50 | ATR:0.013 μM |
| Molecular Weight | 424.5 |
| Formula | C25H24N6O |
| Cas No. | 2713577-16-1 |
| Smiles | C[C@@H]1COCCN1c1nc(nc2ccc(cc12)-c1ccnn1C)-c1cccc2[nH]ccc12 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.